{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:07:13Z","timestamp":1774840033385,"version":"3.50.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,2,1]]},"DOI":"10.2169\/internalmedicine.3617-24","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:12:28Z","timestamp":1720044748000},"page":"343-350","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of Early Gastric Cancer in a Patient with a History of&lt;i&gt; Helicobacter pylori&lt;\/i&gt; Infection and No History of Eradication Therapy"],"prefix":"10.2169","volume":"64","author":[{"given":"Sakiko","family":"Kuraoka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Ino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Practical Gastrointestinal Endoscopy, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Iwamuro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Practical Gastrointestinal Endoscopy, Okayama University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"},{"name":"Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and <i>Helicobacter pylori<\/i>. IARC Monogr Eval Carcinog Risks Hum 61: 177-241, 1994."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Uemura N, Okamoto S, Yamamoto S, et al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.","DOI":"10.1056\/NEJMoa001999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Choi IJ, Kook MC, Kim YI, et al. <i>Helicobacter pylori<\/i> therapy for the prevention of metachronous gastric cancer. N Engl J Med 378: 1085-1095, 2018.","DOI":"10.1056\/NEJMoa1708423"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Fukase K, Kato M, Kikuchi S, et al.; the Japan Gast Study Group. Effect of eradication of <i>Helicobacter pylori<\/i> on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372: 392-397, 2008.","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bae SE, Jung HY, Kang J, et al. Effect of <i>Helicobacter pylori<\/i> eradication on metachronous recurrence after endoscopic resection of gastric neoplasm. Am J Gastroenterol 109: 60-67, 2014.","DOI":"10.1038\/ajg.2013.404"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. <i>Helicobacter pylori<\/i> eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348: g3174, 2014.","DOI":"10.1136\/bmj.g3174"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Yoon SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of <i>Helicobacter pylori<\/i> eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 19: 243-248, 2014.","DOI":"10.1111\/hel.12146"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of <i>Helicobacter pylori<\/i>. J Gastroenterol 46: 318-324, 2011.","DOI":"10.1007\/s00535-010-0347-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of <i>Helicobacter pylori<\/i>: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 21: 1121-1126, 2005.","DOI":"10.1111\/j.1365-2036.2005.02459.x"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yamamoto K, Kato M, Takahashi M, et al. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of <i>Helicobacter pylori<\/i>. Helicobacter 16: 210-216, 2011.","DOI":"10.1111\/j.1523-5378.2011.00833.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsuo T, Ito M, Tatsugami M, et al. Gastric cancer development after <i>Helicobacter pylori<\/i> eradication therapy: a new form of gastric neoplasia. Digestion 85: 61-67, 2012.","DOI":"10.1159\/000335260"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Horiguchi N, Tahara T, Kawamura T, et al. Distinct clinic-pathological features of early differentiated-type gastric cancers after <i>Helicobacter pylori<\/i> eradication. Gastroenterol Res Pract 2016: 8230815, 2016.","DOI":"10.1155\/2016\/8230815"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1: 87-97, 1969.","DOI":"10.1055\/s-0028-1098086"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.","DOI":"10.1097\/00000478-199610000-00001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sanduleanu S, Bruine AD, Stridsberg M, et al. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur J Clin Invest 31: 802-811, 2001.","DOI":"10.1046\/j.1365-2362.2001.00890.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Iwamuro M, Kusumoto C, Nakagawa M, et al. Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without <i>Helicobacter pylori<\/i> infection: a retrospective observational study. BMC Gastroenterol 22: 294, 2022.","DOI":"10.1186\/s12876-022-02368-w"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kodama M, Murakami K, Okimoto T, et al. Histological characteristics of gastric mucosa prior to <i>Helicobacter pylori<\/i> eradication may predict gastric cancer. Scand J Gastroenterol 48: 1249-1256, 2013.","DOI":"10.3109\/00365521.2013.838994"},{"key":"18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gutjnl-2014-307094","volume":"64","author":"K Asada","year":"2015","unstructured":"18. Asada K, Nakajima T, Shimazu T, et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study. Gut 64: 388-396, 2015.","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful <i>Helicobacter pylori<\/i> eradication therapy. Gastric Cancer 19: 524-530, 2016.","DOI":"10.1007\/s10120-015-0479-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kishikawa H, Ojiro K, Nakamura K, et al. Previous <i>Helicobacter pylori<\/i> infection-induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication. Helicobacter 25: e12669, 2020.","DOI":"10.1111\/hel.12669"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ito M, Haruma K, Kamada T, et al. <i>Helicobacter pylori<\/i> eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 16: 1449-1456, 2002.","DOI":"10.1046\/j.1365-2036.2002.01311.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hwang YJ, Choi Y, Kim N, et al. The difference of endoscopic and histologic improvements of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication. Dig Dis Sci 67: 3055-3066, 2022.","DOI":"10.1007\/s10620-021-07146-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ito M, Tanaka S, Maeda M, et al. Role of the gastrin-gastrin receptor system in the expansive growth of human gastric neoplasms. Digestion 78: 163-170, 2008.","DOI":"10.1159\/000181146"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Waldum HL, Rehfeld JF. Gastric cancer and gastrin: on the interaction of <i>Helicobacter pylori<\/i> gastritis and acid inhibitory induced hypergastrinemia. Scand J Gastroenterol 54: 1118-1123, 2019.","DOI":"10.1080\/00365521.2019.1663446"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Weise F, Vieth M, Reinhold D, et al. Gastric cancer in autoimmune gastritis: a case-control study from the German centers of the staR project on gastric cancer research. United European Gastroenterol J 8: 175-184, 2020.","DOI":"10.1177\/2050640619891580"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Kitamura S, Muguruma N, Okamoto K, et al. Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis. JGH Open 5: 1210-1215, 2021.","DOI":"10.1002\/jgh3.12656"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3617-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:34:26Z","timestamp":1738380866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/3\/64_3617-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3617-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"article-number":"3617-24"}}